Minerva Neurosciences (NERV) Short Interest Ratio & Short Volume $1.47 +0.09 (+6.52%) As of 09:55 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Minerva Neurosciences Short Interest DataMinerva Neurosciences (NERV) has a short interest of 27,200 shares, representing 0.50% of the float (the number of shares available for trading by the public). This marks a -1.81% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.3, indicating that it would take 1.3 days of the average trading volume of 28,145 shares to cover all short positions.Current Short Interest27,200 sharesPrevious Short Interest27,700 sharesChange Vs. Previous Month-1.81%Dollar Volume Sold Short$45,424.00Short Interest Ratio1.3 Days to CoverLast Record DateApril 30, 2025Outstanding Shares6,993,000 sharesFloat Size5,440,000 sharesShort Percent of Float0.50%Today's Trading Volume11,052 sharesAverage Trading Volume28,145 sharesToday's Volume Vs. Average39% Short Selling Minerva Neurosciences? Sign up to receive the latest short interest report for Minerva Neurosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNERV Short Interest Over TimeNERV Days to Cover Over TimeNERV Percentage of Float Shorted Over Time Minerva Neurosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202527,200 shares $45,424.00 -1.8%0.5%1.3 $1.67 4/15/202527,700 shares $43,322.80 -12.3%0.5%0.8 $1.56 3/31/202531,600 shares $53,720.00 +21.1%0.6%0.9 $1.70 3/15/202526,100 shares $40,194.00 -54.1%0.5%0.6 $1.54 2/28/202556,900 shares $95,023.00 +35.5%1.1%1.3 $1.67 2/15/202542,000 shares $82,740.00 +101.0%0.8%1 $1.97 1/31/202520,900 shares $48,279.00 +5.0%0.4%0.6 $2.31 1/15/202519,900 shares $42,586.00 +34.5%0.4%0.6 $2.14 12/31/202414,800 shares $32,856.00 +94.7%0.3%0.6 $2.22 12/15/20247,600 shares $16,796.00 -20.0%0.1%0.3 $2.21 Get the Latest News and Ratings for NERV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Minerva Neurosciences and its competitors with MarketBeat's FREE daily newsletter. 11/30/20249,500 shares $21,422.50 -59.4%0.2%0.6 $2.26 11/15/202423,400 shares $51,480.00 +229.6%0.4%1.5 $2.20 10/31/20247,100 shares $17,004.50 -1.4%0.1%0.4 $2.40 10/15/20247,200 shares $19,152.00 -25.0%0.1%0.4 $2.66 9/30/20249,600 shares $25,632.00 +24.7%0.2%0.5 $2.67 9/15/20247,700 shares $22,715.00 -29.4%0.1%0.4 $2.95 8/31/202410,900 shares $29,866.00 -10.7%0.2%0.5 $2.74 8/15/202412,200 shares $32,330.00 -11.0%0.2%0.3 $2.65 7/31/202413,700 shares $40,689.00 -31.8%0.3%0.4 $2.97 7/15/202420,100 shares $67,536.00 +38.6%0.4%0.6 $3.36 6/30/202414,500 shares $46,255.00 -5.8%0.3%0.4 $3.19 6/15/202415,400 shares $51,282.00 -51.4%0.3%0.4 $3.33 5/31/202431,700 shares $80,835.00 +16.1%0.6%0.8 $2.55 5/15/202427,300 shares $70,297.50 +7.1%0.5%0.3 $2.58 4/30/202425,500 shares $60,177.45 -16.4%0.5%0.2 $2.36 4/15/202430,500 shares $73,810.00 -24.3%0.6%0.3 $2.42 3/31/202440,300 shares $103,974.00 +5.2%0.7%0.3 $2.58 3/15/202438,300 shares $106,857.00 -68.7%0.7%0.3 $2.79 2/29/2024122,400 shares $326,808.00 +416.5%2.3%1.1 $2.67 2/15/202423,700 shares $222,780.00 +25.4%0.5%0.3 $9.40 1/31/202418,900 shares $159,705.00 +33.1%0.4%0.5 $8.45 1/15/202414,200 shares $105,790.00 -55.6%0.3%0.5 $7.45 12/31/202332,000 shares $196,800.00 -30.6%0.7%1.3 $6.15 12/15/202346,100 shares $297,345.00 -37.4%1.0%2.3 $6.45 11/30/202373,600 shares $577,760.00 -6.5%1.5%3.6 $7.85 11/15/202378,700 shares $408,453.00 +53.7%1.6%4.2 $5.19 10/31/202351,200 shares $246,784.00 +4.5%1.1%2.4 $4.82 10/15/202349,000 shares $279,790.00 -17.0%1.0%1.8 $5.71 9/30/202359,000 shares $407,100.00 -20.3%1.2%1.3 $6.90 9/15/202374,000 shares $575,720.00 -7.9%1.5%0.1 $7.78Elon Reveals Why There Soon Won’t Be Any Money For Social Security (Ad)Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a terrifying supercar crash with billionaire Peter Thiel, then from a deadly strain of malaria—Elon Musk emerged with a stark warning for Americans about looming financial dangers. Discover the little-known Trump IRS loophole that thousands are now using to safeguard their retirement from inflation and market turmoil—before it's too late.See why thousands of forward-thinking retirement savers are now requesting this FREE 2025 Wealth Pro 8/31/202380,300 shares $672,111.00 -21.1%1.9%0.1 $8.37 8/15/2023101,800 shares $911,110.00 -17.0%2.4%0.1 $8.95 7/31/2023122,700 shares $1.17 million +16.6%2.9%0.1 $9.51 7/15/2023105,200 shares $1.27 million -75.8%3.1%0.1 $12.07 6/30/2023434,000 shares $3.97 million +540.1%12.8%0.4 $9.14 6/15/202367,800 shares $496,296.00 -49.8%1.5%0.3 $7.32 5/31/2023135,000 shares $805,950.00 -54.6%2.9%0.7 $5.97 5/15/2023297,300 shares $1.91 million +263.5%6.4%1.6 $6.44 4/30/202381,800 shares $229,040.00 -22.7%1.8%0.5 $2.80 4/15/2023105,800 shares $241,224.00 +27.2%2.3%1.7 $2.28 3/31/202383,200 shares $133,120.00 -8.0%1.8%1.1 $1.60 3/15/202390,400 shares $157,296.00 -20.1%2.0%1 $1.74 2/28/2023113,200 shares $244,512.00 +15.9%2.5%1.2 $2.16 2/15/202397,700 shares $230,572.00 -4.0%2.2%1 $2.36 1/31/2023101,800 shares $243,302.00 -41.5%2.2%0.6 $2.39 1/15/2023174,100 shares $386,502.00 +20.2%3.8%1 $2.22 12/30/2022144,900 shares $230,391.00 -26.6%3.2%0.5 $1.59 12/15/2022197,300 shares $554,413.00 -21.5%4.3%0.6 $2.81 11/30/2022251,300 shares $889,602.00 +0.8%5.5%0.6 $3.54 11/15/2022249,200 shares $859,740.00 +79.3%5.5%0.1 $3.45 10/31/2022139,000 shares $368,350.00 -57.2%3.1%0 $2.65 10/15/2022324,600 shares $4.36 million -43.4%7.1%0.1 $13.43 9/30/2022573,400 shares $5.29 million -47.4%12.6%0.1 $9.23 9/15/20221,090,000 shares $9.88 million -31.9%24.0%0.2 $9.06 8/31/20221,600,000 shares $18.05 million +787.4%35.2%0.3 $11.28 8/15/2022180,300 shares $558,930.00 +254.2%4.0%0.1 $3.10 7/31/202250,900 shares $136,412.00 -8.9%1.0%0.1 $2.68 7/15/202255,900 shares $169,936.00 +12.9%1.1%1.9 $3.04 6/30/202249,500 shares $163,845.00 -8.5%1.0%1.8 $3.31 6/15/202254,100 shares $178,746.40 -78.4%N/A2.4 $3.30 5/31/2022250,500 shares $100,200.00 +11.3%0.6%1.8 $0.40 5/15/2022225,100 shares $86,663.50 -0.9%0.6%2.5 $0.39 4/30/2022227,200 shares $115,872.00 -5.5%0.6%2.3 $0.51 4/15/2022240,500 shares $187,349.50 -21.7%0.6%2.3 $0.78 3/31/2022307,000 shares $254,871.40 -13.9%0.7%2.7 $0.83 3/15/2022356,500 shares $238,855.00 -2.1%0.9%2.1 $0.67 2/28/2022364,300 shares $257,195.80 -15.5%0.9%1.8 $0.71 2/15/2022431,200 shares $340,648.00 -16.8%1.1%1.4 $0.79 1/31/2022518,500 shares $427,969.90 +16.3%1.3%1.2 $0.83 1/15/2022445,900 shares $372,281.91 +18.5%1.1%0.9 $0.83 12/31/2021376,300 shares $301,416.30 -19.8%0.9%0.7 $0.80 12/15/2021469,300 shares $407,352.40 -22.5%1.1%0.7 $0.87 11/30/2021605,600 shares $588,037.60 -13.0%1.5%0.9 $0.97 11/15/2021696,200 shares $898,098.00 -62.0%1.7%1 $1.29 10/29/20211,830,000 shares $2.56 million +1.1%4.5%3 $1.40 10/15/20211,810,000 shares $2.44 million -8.6%4.4%2.9 $1.35 9/30/20211,980,000 shares $3.45 million -3.4%4.8%3 $1.74 9/15/20212,050,000 shares $3.42 million -6.0%5.0%3 $1.67 8/31/20212,180,000 shares $4.01 million +5.3%5.3%3.5 $1.84 8/13/20212,070,000 shares $3.50 million +6.2%5.0%3.3 $1.69Elon Reveals Why There Soon Won’t Be Any Money For Social Security (Ad)Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a terrifying supercar crash with billionaire Peter Thiel, then from a deadly strain of malaria—Elon Musk emerged with a stark warning for Americans about looming financial dangers. Discover the little-known Trump IRS loophole that thousands are now using to safeguard their retirement from inflation and market turmoil—before it's too late.See why thousands of forward-thinking retirement savers are now requesting this FREE 2025 Wealth Pro 7/30/20211,950,000 shares $3.59 million -3.5%4.7%1.1 $1.84 7/15/20212,020,000 shares $4.08 million -2.9%4.9%1.2 $2.02 6/30/20212,080,000 shares $4.83 million -37.9%5.1%1.3 $2.32 6/15/20213,350,000 shares $9.38 million No Change8.1%2.2 $2.80 5/28/20213,350,000 shares $9.88 million -34.7%8.1%2.3 $2.95 5/14/20215,130,000 shares $13.80 million +85.9%N/A3.5 $2.69 4/30/20212,760,000 shares $6.71 million +9.1%N/A6.5 $2.43 4/15/20212,530,000 shares $6.15 million +5.0%N/A6.1 $2.43 3/31/20212,410,000 shares $7.09 million -1.6%N/A3.8 $2.94 3/15/20212,450,000 shares $8.18 million No ChangeN/A3.5 $3.34 2/26/20212,450,000 shares $7.89 million +14.0%N/A3 $3.22 2/12/20212,150,000 shares $7.63 million +6.4%6.0%2.4 $3.55 1/29/20212,020,000 shares $6.42 million +6.3%5.8%2.3 $3.18 1/15/20211,900,000 shares $5.11 million -11.6%5.4%2.2 $2.69 12/31/20202,150,000 shares $5.14 million +7.5%6.1%3.4 $2.39 12/15/20202,000,000 shares $5.30 million -0.5%5.7%3.3 $2.65 11/30/20202,010,000 shares $8.06 million -19.9%5.7%3.2 $4.01 11/15/20202,510,000 shares $8.94 million -14.0%7.2%4.8 $3.56 10/30/20202,920,000 shares $9.46 million -12.6%8.2%5.2 $3.24 10/15/20203,340,000 shares $11.22 million -5.7%9.8%4.7 $3.36 9/30/20203,540,000 shares $11.26 million -7.8%10.3%4.2 $3.18 9/15/20203,840,000 shares $12.67 million -13.1%11.2%3.6 $3.30 8/31/20204,420,000 shares $14.06 million -3.9%12.9%3.4 $3.18 8/14/20204,600,000 shares $15.59 million -14.0%13.6%1.3 $3.39 7/31/20205,350,000 shares $18.62 million -17.8%16.2%1.5 $3.48 7/15/20206,510,000 shares $21.48 million -7.0%20.7%1.9 $3.30 6/30/20207,000,000 shares $24.36 million -0.3%22.2%2.1 $3.48 6/15/20207,020,000 shares $25.83 million +118.7%22.3%2.3 $3.68 5/29/20203,210,000 shares $11.91 million +20.2%10.2%1.2 $3.71 NERV Short Interest - Frequently Asked Questions What is Minerva Neurosciences' current short interest? Short interest is the volume of Minerva Neurosciences shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 27,200 shares of NERV short. 0.50% of Minerva Neurosciences' shares are currently sold short. Learn More on Minerva Neurosciences' current short interest. What is a good short interest ratio for Minerva Neurosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NERV shares currently have a short interest ratio of 1.0. Learn More on Minerva Neurosciences's short interest ratio. What is a good short interest percentage for Minerva Neurosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.50% of Minerva Neurosciences' floating shares are currently sold short. Is Minerva Neurosciences' short interest increasing or decreasing? Minerva Neurosciences saw a drop in short interest in April. As of April 30th, there was short interest totaling 27,200 shares, a drop of 1.8% from the previous total of 27,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Minerva Neurosciences' float size? Minerva Neurosciences currently has issued a total of 6,993,000 shares. Some of Minerva Neurosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Minerva Neurosciences currently has a public float of 5,440,000 shares. How does Minerva Neurosciences' short interest compare to its competitors? 0.50% of Minerva Neurosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Minerva Neurosciences: Mural Oncology plc (7.01%), Quince Therapeutics, Inc. (3.12%), Century Therapeutics, Inc. (7.07%), Kronos Bio, Inc. (1.71%), Biodexa Pharmaceuticals Plc (0.62%), Mersana Therapeutics, Inc. (8.45%), PMV Pharmaceuticals, Inc. (1.96%), Werewolf Therapeutics, Inc. (6.49%), Connect Biopharma Holdings Limited (0.09%), Lantern Pharma Inc. (3.17%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Minerva Neurosciences stock? Short selling NERV is an investing strategy that aims to generate trading profit from Minerva Neurosciences as its price is falling. NERV shares are trading up $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Minerva Neurosciences? A short squeeze for Minerva Neurosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NERV, which in turn drives the price of the stock up even further. How often is Minerva Neurosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NERV, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies MURA Short Squeeze QNCX Short Squeeze IPSC Short Squeeze KRON Short Squeeze BDRX Short Squeeze MRSN Short Squeeze PMVP Short Squeeze HOWL Short Squeeze CNTB Short Squeeze LTRN Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NERV) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredTrump + Musk = AI’s turning pointTrump may not code… but he knows how to pick winners. And according to insiders, his administration is prep...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Minerva Neurosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Minerva Neurosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NERV Stock Free NERV Stock Alerts